Cited by 125Digestive system and related healthGastrointestinal motility and disordersCancer Cells and Metastasis

Human mini-guts: New insights into intestinal physiology and host–pathogen interactions

Open access
In, Julie G., Foulke-Abel, Jennifer, Estes, Mary K., Zachos, Nicholas C., Kovbasnjuk, Olga, Donowitz, Mark·2016·Nature Reviews Gastroenterology & Hepatology

Abstract

The development of indefinitely propagating human 'mini-guts' has led to a rapid advance in gastrointestinal research related to transport physiology, developmental biology, pharmacology, and pathophysiology. These mini-guts, also called enteroids or colonoids, are derived from LGR5+ intestinal stem cells isolated from the small intestine or colon. Addition of WNT3A and other growth factors promotes stemness and results in viable, physiologically functional human intestinal or colonic cultures that develop a crypt-villus axis and can be differentiated into all intestinal epithelial cell types. The success of research using human enteroids has highlighted the limitations of using animals or in vitro, cancer-derived cell lines to model transport physiology and pathophysiology. For example, curative or preventive therapies for acute enteric infections have been limited, mostly due to the lack of a physiological human intestinal model. However, the human enteroid model enables specific functional studies of secretion and absorption in each intestinal segment as well as observations of the earliest molecular events that occur during enteric infections. This Review describes studies characterizing these human mini-guts as a physiological model to investigate intestinal transport and host-pathogen interactions.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/nrgastro.2016.142

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Immortalized colon cancer cell lines such as Caco-2, HT-29, and T84 contain vastly mutated genomes and altered transcriptional and metabolic profiles.

    “Until recently, human cell culture models for studying intestinal epithelial cell transport have generally used colon cancer cell lines such as Caco-2, HT-29, and T84 [38,39], which are immortalized and contain vastly mutated genomes in addition to altered transcriptional and metabolic profiles [40].”

    From Regulation of Enterocyte Brush Border Membrane Primary Na-Absorptive Transporters in Human Intestinal Organoid-Derived Monolayers (2024) · cites this paper as [40]

    The “Limitations of traditional intestinal models” section identifies Caco-2, HT29 and T84 as immortalized, cancer-derived cell lines and reports differences in protein expression from the human intestine. It does not say that their genomes are vastly mutated or that they have altered metabolic profiles; its protein-expression findings do not establish the broader claim about transcriptional profiles. (LLM, conf=0.86)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 89

  1. [1]Seidler UE Gastrointestinal HCO3− transport and epithelial protection in the gut: new techniques, transport pathways and regulatory pathways Curr Opin Pharmacol 13 900 908 2013 24280619
  2. [2]Canny GO McCormick BA Bacteria in the intestine, helpful residents or enemies from within? Infect Immun 76 3360 33738 2008 18474643 PMC2493210
  3. [3]Heath JP Epithelial cell migration in the intestine Cell Biol Int 20 139 146 1996 8935158
  4. [4]Cheng H Bjerknes M Whole population cell kinetics and postnatal development of the mouse intestinal epithelium Anat Rec 211 420 426 1985 3993991
  5. [5]Barker N Adult intestinal stem cells: critical drivers of epithelial homeostasis and regeneration Nat Rev Mol Cell Biol 15 19 33 2013 24326621
  6. [6]Artursson P Epithelial transport of drugs in cell culture. I: a model for studying the passive diffusion of drugs over intestinal absorptive (Caco-2) cells J Pharm Sci 79 476 482 1990 1975619
  7. [7]Middendorp S Adult stem cells in the small intestine are intrinsically programmed with their location-specific function Stem Cells 32 1083 1091 2014 24496776
  8. [8]Foulke-Abel J Human enteroids as a model of upper small intestinal ion transport physiology and pathophysiology Gastroenterology 150 638 649 2015 26677983 PMC4766025
  9. [10]McCracken KW Howell JC Wells JM Spence JR Generating human intestinal tissue from pluripotent stem cells in vitro. Nat Protoc 6 1920 1928 2011 22082986 PMC3896236
  10. [12]Casburn-Jones AC Management of infectious diarrhoea Gut 53 296 305 2004 14724167 PMC1774945
  11. [13]Thiagarajah JR Donowitz M Verkman AS Secretory diarrhoea: mechanisms and emerging therapies Nat Rev Gastroenterol Hepatol 12 446 457 2015 26122478 PMC4786374
  12. [14]Hilgers AR Conradi RA Burton PS Caco-2 cell monolayers as a model for drug transport across the intestinal mucosa Pharm Res 7 902 910 1990 2235888
  13. [15]Nataro JP Hicks S Phillips AD Vial PA Sears CL T84 cells in culture as a model for enteroaggregative Escherichia coli pathogenesis Infect Immun 64 4761 4768 1996 8890237 PMC174443
  14. [16]Huet C Sahuquillo-Merino C Coudrier E Louvard D Absorptive and mucus-secreting subclones isolated from a multipotent intestinal cell line (HT-29) provide new models for cell polarity and terminal differentiation J Cell Biol 105 345 357 1987 3611191 PMC2114933
  15. [17]Larregieu CA Benet LZ Drug discovery and regulatory considerations for improving in silico and in vitro predictions that use Caco-2 as a surrogate for human intestinal permeability measurements AAPS J 15 483 497 2013 23344793 PMC3675726
  16. [18]Sun D Comparison of human duodenum and Caco-2 gene expression profiles for 12,000 gene sequences tags and correlation with permeability of 26 drugs Pharm Res 19 1400 1416 2002 12425456
  17. [19]Awortwe C Fasinu PS Rosenkranz B Application of Caco-2 cell line in herb–drug interaction studies: current approaches and challenges J Pharm Pharm Sci 17 1 19 2014 24735758 PMC4355448
  18. [20]Artursson P Palm K Luthman K Caco-2 monolayers in experimental and theoretical predictions of drug transport Adv Drug Deliv Rev 46 27 43 2001 11259831
  19. [21]Hughes P Marshall D Reid Y Parkes H Gelber C The costs of using unauthenticated, over-passaged cell lines: how much more data do we need? BioTechniques 43 575 586 2007 18072586
  20. [22]Markert T Endogenous expression of type II cGMP-dependent protein kinase mRNA and protein in rat intestine. Implications for cystic fibrosis transmembrane conductance regulator J Clin Invest 96 822 830 1995 7543493 PMC185268
  21. [23]Vaandrager AB Differential role of cyclic GMP-dependent protein kinase II in ion transport in murine small intestine and colon Gastroenterology 118 108 114 2000 10611159
  22. [24]van der Mark VA The lipid flippase heterodimer ATP8B1–CDC50A is essential for surface expression of the apical sodium-dependent bile acid transporter (SLC10A2/ASBT) in intestinal Caco-2 cells Biochim Biophys Acta 1842 2378 2386 2014 25239307
  23. [25]Johansson MEV The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria Proc Natl Acad Sci USA 105 15064 15069 2008 18806221 PMC2567493
  24. [26]Erdem AL Avelino F Xicohtencatl-Cortes J Giron JA Host protein binding and adhesive properties of H6 and H7 flagella of attaching and effacing Escherichia coli J Bacteriol 189 7426 7435 2007 17693516 PMC2168434
  25. [27]Pacheco AR Fucose sensing regulates bacterial intestinal colonization Nature 492 113 117 2012 23160491 PMC3518558
  26. [28]Spence JR Directed differentiation of human pluripotent stem cells into intestinal tissue in vitro Nature 470 105 109 2011 21151107 PMC3033971
  27. [29]Finkbeiner SR Transcriptome-wide analysis reveals hallmarks of human intestine development and maturation in vitro and in vivo Stem Cell Reports 4 1140 1155 2015 PMC4471827 26050928
  28. [30]Watson CL An in vivo model of human small intestine using pluripotent stem cells Nat Med 20 1310 1314 2014 25326803 PMC4408376
  29. [31]Wells JM Spence JR How to make an intestine Development 141 752 760 2014 24496613 PMC3912826
  30. [32]Sinagoga KL Wells JM Generating human intestinal tissues from pluripotent stem cells to study development and disease EMBO J 34 1149 1163 2015 25792515 PMC4426477
  31. [33]Stelzner M A nomenclature for intestinal in vitro cultures Am J Physiol Gastrointest Liver Physiol 302 G1359 G1363 2012 22461030 PMC3378093
  32. [36]Zachos NC Human enteroids/colonoids and intestinal organoids functionally recapitulate normal intestinal physiology and pathophysiology J Biol Chem 291 3759 3766 2015 26677228 PMC4759158
  33. [37]Sato T Clevers H Growing self-organizing mini-guts from a single intestinal stem cell: mechanism and applications Science 340 1190 1194 2013 23744940
  34. [38]Kovbasnjuk O Human enteroids: preclinical models of non-inflammatory diarrhea Stem Cell Res Ther 4 Suppl 1 S3 2013 24564938 PMC4029787
  35. [40]Fujii M Matano M Nanki K Sato T Efficient genetic engineering of human intestinal organoids using electroporation Nat Protoc 10 1474 1485 2015 26334867
  36. [41]Drost J Sequential cancer mutations in cultured human intestinal stem cells Nature 521 43 47 2015 25924068
  37. [42]Date S Sato T Mini-gut organoids: reconstitution of stem cell niche Annu Rev Cell Dev Biol 31 269 289 2015 26436704
  38. [43]de Lau W Peyer’s patch M cells derived from Lgr5+ stem cells require SpiB and are induced by RankL in cultured “miniguts” Mol Cell Biol 32 3639 3647 2012 22778137 PMC3430189
  39. [45]Matano M Modeling colorectal cancer using CRISPR–Cas9-mediated engineering of human intestinal organoids Nat Med 21 256 262 2015 25706875
  40. [47]Dekkers JF A functional CFTR assay using primary cystic fibrosis intestinal organoids Nat Med 19 939 945 2013 23727931
  41. [48]Turnberg LA Bieberdorf FA Morawski SG Fordtran JS Interrelationships of chloride, bicarbonate, sodium, and hydrogen transport in the human ileum J Clin Invest 49 557 567 1970 5415682 PMC322504
  42. [49]Turnberg LA Fordtran JS Carter NW Rector FC Mechanism of bicarbonate absorption and its relationship to sodium transport in the human jejunum J Clin Invest 49 548 556 1970 5415681 PMC322503
  43. [50]Kunzelmann K Mall M Electrolyte transport in the mammalian colon: mechanisms and implications for disease Physiol Rev 82 245 289 2002 11773614
  44. [51]Frizzell RA Field M Schultz SG Sodium-coupled chloride transport by epithelial tissues Am J Physiol Renal Physiol 236 F1 F8 1979 219705
  45. [52]Field M Fromm D Al-Awqati Q Greenough WB Effect of cholera enterotoxin on ion transport across isolated ileal mucosa J Clin Invest 51 796 804 1972 4335444 PMC302193
  46. [53]Field M Graf LH Jr Laird WJ Smith PL Heat-stable enterotoxin of Escherichia coli: in vitro effects on guanylate cyclase activity, cyclic GMP concentration, and ion transport in small intestine Proc Natl Acad Sci USA 75 2800 2804 1978 26915 PMC392652
  47. [54]Dharmsathaphorn K Mandel KG Masui H McRoberts JA Vasoactive intestinal polypeptide-induced chloride secretion by a colonic epithelial cell line. Direct participation of a basolaterally localized Na+, K+, Cl− cotransport system J Clin Invest 75 462 471 1985 2579099 PMC423520
  48. [55]Mandel KG Dharmsathaphorn K McRoberts JA Characterization of a cyclic AMP-activated Cl− tranport pathway in the apical membrane of a human colonic epithelial cell line J Biol Chem 261 704 712 1986 3001077
  49. [56]Dharmsathaphorn K Pandol SJ Mechanism of chloride secretion induced by carbachol in a colonic epithelial cell line J Clin Invest 77 348 354 1986 3003156 PMC423353
  50. [57]Musch MW Arvans DL Wu GD Chang EB Functional coupling of the downregulated in adenoma Cl−/base exchanger DRA and the apical Na+/H+ exchangers NHE2 and NHE3 Am J Physiol Gastrointest Liver Physiol 296 G202 G210 2009 19056765 PMC2643907
  51. [58]Mizutani T Real-time analysis of P-glycoprotein-mediated drug transport across primary intestinal epithelium three-dimensionally cultured in vitro Biochem Biophys Res Commun 419 238 243 2012 22342245
  52. [59]Grant CN Human and mouse tissue-engineered small intestine both demonstrate digestive and absorptive function Am J Physiol Gastrointest Liver Physiol 308 G664 G677 2014 PMC4398842 25573173
  53. [60]Saxena K Human intestinal enteroids: a new model to study human rotavirus infection, host restriction, and pathophysiology J Virol 90 43 56 2016 PMC4702582 26446608
  54. [61]Walker NM Cellular chloride and bicarbonate retention alters intracellular pH regulation in Cftr KO crypt epithelium Am J Physiol Gastrointest Liver Physiol 310 G70 G80 2015 26542396 PMC4719062
  55. [62]Abba K Sinfield R Hart CA Garner P Pathogens associated with persistent diarrhoea in children in low and middle income countries: systematic review BMC Infect Dis 9 88 2009 19515227 PMC2709113
  56. [63]Fletcher SM McLaws ML Ellis JT Prevalence of gastrointestinal pathogens in developed and developing countries: systemic review and meta-analysis J Public Health Res 2 42 53 2013 25170480 PMC4140330
  57. [64]Page AL Geographic distribution and mortality risk factors during the cholera outbreak in a rural region of Haiti, 2010–2011 PLoS Negl Trop Dis 9 e0003605 2015 25811860 PMC4374668
  58. [65]Jenkins C Public health investigation of two outbreaks of Shiga toxin-producing Escherichia coli O157 associated with consumption of watercress Appl Environ Microbiol 81 3946 3952 2015 25841005 PMC4524134
  59. [66]Luna-Gierke RE Outbreaks of non-O157 Shiga toxin-producing Escherichia coli infection: USA Epidemiol Infect 142 2270 2280 2014 24398154 PMC9151257
  60. [67]Navarro-Garcia F Escherichia coli O104:H4 pathogenesis: an enteroaggregative E. coli/Shiga toxin-producing E. coli explosive cocktail of high virulence Microbiol Spectr 2 533 539 2014 26104460
  61. [68]Warny M Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe Lancet 366 1079 1084 2005 16182895
  62. [69]Martinez F Clostridium difficile outbreaks: prevention and treatment strategies Risk Manag Healthc Policy 5 55 64 2012 22826646 PMC3401971
  63. [70]Brown K Valenta K Fisman D Simor A Daneman N Hospital ward antibiotic prescribing and the risks of Clostridium difficile Infection JAMA Intern Med 175 626 633 2015 25705994
  64. [71]Davies J Davies D Origins and evolution of antibiotic resistance Microbiol Mol Biol Rev 74 417 433 2010 20805405 PMC2937522
  65. [72]Garner CD Perturbation of the small intestine microbial ecology by streptomycin alters pathology in a Salmonella enterica Serovar Typhimurium murine model of infection Infect Immun 77 2691 2702 2009 19433544 PMC2708583
  66. [73]Hodges K Gill R Infectious diarrhea cellular and molecular mechanisms Gut Microbes 1 4 21 2010 21327112 PMC3035144
  67. [74]Willing BP Russell SL Finlay BB Shifting the balance: antibiotic effects on host–microbiota mutualism Nat Rev Microbiol 9 233 243 2011 21358670
  68. [75]Jiminez JA Uwiera TC Douglas Inglis G Uwiera RRE Animal models to study acute and chronic intestinal inflammation in mammals Gut Pathog 7 29 2015 26561503 PMC4641401
  69. [76]Engevik MA Human Clostridium difficile infection: altered mucus production and composition Am J Physiol Gastrointest Liver Physiol 308 G510 G524 2014 25552581 PMC4422372
  70. [77]Leslie JL Persistence and toxin production by Clostridium difficile within human intestinal organoids result in disruption of epithelial paracellular barrier function Infect Immun 83 138 145 2015 25312952 PMC4288864
  71. [78]Engevik MA Human Clostridium difficile infection: inhibition of NHE3 and microbiota profile Am J Physiol Gastrointest Liver Physiol 308 G497 G509 2014 25552580 PMC4422371
  72. [79]Hayashi H Inhibition and redistribution of NHE3, the apical Na+/H+ exchanger, by Clostridium difficile toxin B J Gen Physiol 123 491 504 2004 15078917 PMC2234495
  73. [80]Forbester JL Interaction of Salmonella enterica serovar Typhimurium with intestinal organoids derived from human induced pluripotent stem cells Infect Immun 83 2926 2934 2015 25964470 PMC4468523
  74. [81]Finkbeiner SR Stem cell-derived human intestinal organoids as an infection model for rotaviruses mBio 3 e00159 12 2012 22761392 PMC3398537
  75. [82]Yin Y Modeling rotavirus infection and antiviral therapy using primary intestinal organoids Antiviral Res 123 120 131 2015 26408355
  76. [83]VanDussen KL Development of an enhanced human gastrointestinal epithelial culture system to facilitate patient-based assays Gut 64 911 920 2015 25007816 PMC4305344
  77. [84]Ermund A Schutte A Johansson MEV Gustafsson JK Hansson GC Studies of mucus in mouse stomach, small intestine, and colon. I Gastrointestinal mucus layers have different properties depending on location as well as over the Peyer’s patches Am J Physiol Gastrointest Liver Physiol 305 G341 G347 2013 23832518 PMC3761247
  78. [85]Johansson MEV Sjövall H Hansson GC The gastrointestinal mucus system in health and disease Nat Rev Gastroenterol Hepatol 10 352 361 2013 23478383 PMC3758667
  79. [86]Stange Daniel E Differentiated Troy+ chief cells act as reserve stem cells to generate all lineages of the stomach epithelium Cell 155 357 368 2013 24120136 PMC4094146
  80. [87]Bartfeld S In vitro expansion of human gastric epithelial stem cells and their responses to bacterial infection Gastroenterology 148 126 136.e6 2015 25307862 PMC4274199
  81. [88]Schlaermann P A novel human gastric primary cell culture system for modelling Helicobacter pylori infection in vitro Gut 65 202 213 2014 25539675 PMC4752654
  82. [89]Barker N Lgr5+ve stem cells drive self-renewal in the stomach and build long-lived gastric units in vitro Cell Stem Cell 6 25 36 2010 20085740
  83. [91]Chen YJ De novo formation of insulin-producing “neo-β cell islets” from intestinal crypts Cell Rep 6 1046 1058 2014 24613355 PMC4245054
  84. [92]Guye P Genetically engineering self-organization of human pluripotent stem cells into a liver bud-like tissue using Gata6 Nat Commun 7 10243 2016 26732624 PMC4729822
  85. [93]Huch M In vitro expansion of single Lgr5+ liver stem cells induced by Wnt-driven regeneration Nature 494 247 250 2013 23354049 PMC3634804
  86. [95]Park JG Characteristics of cell lines established from human gastric carcinoma Cancer Res 50 2773 2780 1990 2158397
  87. [96]Leite M Figueiredo CA Method for short-term culture of human gastric epithelial cells to study the effects of Helicobacter pylori 921 61 68 2012 23015492
  88. [98]Bertaux-Skeirik N CD44 plays a functional role in Helicobacter pylori-induced epithelial cell proliferation PLOS Pathog 11 e1004663 2015 25658601 PMC4450086
  89. [99]Takaishi S Identification of gastric cancer stem cells using the cell surface marker CD44 Stem Cells 27 1006 1020 2009 19415765 PMC2746367

Cited by

Sorted by citations

Authors
In, J. G., Foulke-Abel, J., Estes, M. K., Zachos, N. C., Kovbasnjuk, O., & Donowitz, M.
Affiliations
  • Johns Hopkins University (US)
  • Baylor College of Medicine (US)
Corresponding author
Donowitz, Mark
Venue
Nature Reviews Gastroenterology & Hepatology
Published
2016-09-28
Volume
13
Issue
11
Pages
633-642
ISSN
  • 1759-5045 (ISSN-L)
  • 1759-5053
OpenAlex
W2526238900
Cited by
125
References
11
Citations by year
2026: 2 · 2025: 12 · 2024: 6 · 2023: 6 · 2022: 17 · 2021: 20 · 2020: 17 · 2019: 12 · 2018: 15 · 2017: 17
FWCI
1.96
Type
journal article
Language
en
Open access
Locations
  • Nature Reviews Gastroenterology & Hepatology (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institutes of Health (UH3TR000504, UH3TR000503)
  • National Institute of Allergy and Infectious Diseases (R01AI080656, U19AI116497)
  • National Institute of Diabetes and Digestive and Kidney Diseases (U24DK085532, T32DK007632, P30DK089502, K01DK106323, R01DK061765, R01DK026523, U01DK085532)
  • National Center for Advancing Translational Sciences
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Digestive system and related health
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
  • Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
Keywords
colonoids, intestinal organoids, Lgr5+ intestinal stem cells, Wnt3a, host-pathogen interaction, gastrointestinal infections, intestinal epithelial differentiation, crypt-villus axis, in vitro intestinal model
MeSH terms
Biological Transport, Forecasting, Gastrointestinal Diseases, Humans, Infections, Intestine, Large, Intestine, Small, Models, Biological, Organoids, Host-Pathogen Interactions

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review